Health Care·Health Care Equipment·$158.4B
| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $1.50 | N/A | +0.20% |
management commentary, guidance changes, and full analysis available with Pro.
| +0.20% |
Tone: Defensive
Overall, management expressed concern about current market conditions but highlighted efforts to maintain financial stability. They did not provide specific guidance for the upcoming quarters.
Management acknowledged ongoing challenges in the market.
They emphasized a focus on cost management and operational efficiency.
Abbott Labs reported better-than-expected earnings per share, but the stock dropped significantly by over 10%. Investors may be reacting to the lack of revenue details and the absence of guidance, indicating uncertainty about future performance. The defensive tone from management suggests they are cautious about upcoming challenges in the market.
AI-powered briefs, options data, and 20 quarters of history — everything you need before earnings.
No charge today · Auto-bills $8/mo after 7 days · Cancel anytime
D R HORTON INC
Jan 20, 2026